Amie Goodin

1.7k total citations
112 papers, 1.1k citations indexed

About

Amie Goodin is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Amie Goodin has authored 112 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Public Health, Environmental and Occupational Health, 37 papers in Pediatrics, Perinatology and Child Health and 32 papers in Pharmacology. Recurrent topics in Amie Goodin's work include Opioid Use Disorder Treatment (33 papers), Prenatal Substance Exposure Effects (27 papers) and Cannabis and Cannabinoid Research (26 papers). Amie Goodin is often cited by papers focused on Opioid Use Disorder Treatment (33 papers), Prenatal Substance Exposure Effects (27 papers) and Cannabis and Cannabinoid Research (26 papers). Amie Goodin collaborates with scholars based in United States, United Kingdom and Taiwan. Amie Goodin's co-authors include Joshua D. Brown, Amanda Fallin, Jeffery Talbert, Patricia R. Freeman, Juan M. Hincapie‐Castillo, Youn Ok Lee, Brian A. King, Traci C. Green, Wei‐Hsuan Lo‐Ciganic and Scott Martin Vouri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Amie Goodin

100 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Amie Goodin 457 258 213 198 181 112 1.1k
Philip Clare 486 1.1× 381 1.5× 247 1.2× 105 0.5× 271 1.5× 58 1.3k
Anaïs Lacasse 545 1.2× 123 0.5× 260 1.2× 511 2.6× 233 1.3× 83 1.5k
Julie Dupouy 532 1.2× 348 1.3× 157 0.7× 89 0.4× 94 0.5× 59 942
Stephen G. Henry 698 1.5× 193 0.7× 158 0.7× 176 0.9× 499 2.8× 65 1.4k
Gerald Cochran 1.1k 2.4× 577 2.2× 323 1.5× 131 0.7× 291 1.6× 116 1.6k
Hillary V. Kunins 1.0k 2.3× 695 2.7× 306 1.4× 119 0.6× 255 1.4× 53 1.6k
Darshak Sanghavi 784 1.7× 612 2.4× 254 1.2× 117 0.6× 653 3.6× 40 2.1k
Omid Ameli 641 1.4× 433 1.7× 225 1.1× 175 0.9× 132 0.7× 29 1.1k
Babak Tofighi 669 1.5× 628 2.4× 121 0.6× 89 0.4× 288 1.6× 65 1.4k
Lalitha Raman‐Wilms 359 0.8× 79 0.3× 227 1.1× 108 0.5× 304 1.7× 39 1.2k

Countries citing papers authored by Amie Goodin

Since Specialization
Citations

This map shows the geographic impact of Amie Goodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amie Goodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amie Goodin more than expected).

Fields of papers citing papers by Amie Goodin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amie Goodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amie Goodin. The network helps show where Amie Goodin may publish in the future.

Co-authorship network of co-authors of Amie Goodin

This figure shows the co-authorship network connecting the top 25 collaborators of Amie Goodin. A scholar is included among the top collaborators of Amie Goodin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amie Goodin. Amie Goodin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Jingchuan, et al.. (2025). Suicide risk after abrupt discontinuation of long-term opioid therapy: an observational cohort study. Pain Medicine. 26(10). 631–642.
2.
3.
Goodin, Amie, et al.. (2025). Quantitative analysis of Δ8- and Δ9-tetrahydrocannabinol metabolites and isomers: a rapid assay in urine by LC-MS/MS. Analytical and Bioanalytical Chemistry. 417(8). 1507–1518. 3 indexed citations
4.
Grundmann, Oliver, et al.. (2025). Neurodevelopmental effects of perinatal exposure to cannabis on progeny: A narrative review. Drug and Alcohol Dependence Reports. 16. 100372–100372.
5.
Wang, Grace Hsin‐Min, et al.. (2025). Machine Learning Algorithms for Predicting Injurious Fall Risk Among Older Adults With Depression: A Prognostic Modeling Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 46(2). e70087–e70087.
6.
Osborne, Vicki, Amie Goodin, Joshua D. Brown, et al.. (2024). Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry. Pharmacoepidemiology and Drug Safety. 33(4). e5789–e5789.
7.
Noor‐E‐Alam, Md., Gary J. Young, Wei‐Hsuan Lo‐Ciganic, et al.. (2024). An explainable machine learning framework for predicting the risk of buprenorphine treatment discontinuation for opioid use disorder among commercially insured individuals. Computers in Biology and Medicine. 177. 108493–108493. 4 indexed citations
8.
Goodin, Amie, et al.. (2024). Proceedings of the 2024 Cannabis Clinical Outcomes Research Conference. SHILAP Revista de lepidopterología. 7(1). 213–217.
9.
Wang, Grace Hsin‐Min, et al.. (2024). Injurious Fall Risk Differences Among Older Adults With First-Line Depression Treatments. JAMA Network Open. 7(8). e2435535–e2435535. 3 indexed citations
10.
Vouri, Scott Martin, et al.. (2024). Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment. Pharmacoepidemiology and Drug Safety. 33(8). e5852–e5852. 1 indexed citations
11.
Chen, Aokun, John M. Allen, Yi Guo, et al.. (2024). Social determinants of health and newer glucose-lowering drugs adoption among US Medicare beneficiaries with type 2 diabetes. Journal of Managed Care & Specialty Pharmacy. 30(11). 1298–1307. 1 indexed citations
12.
Goodin, Amie, et al.. (2024). Trajectories of Adherence to Oral Pre-exposure Prophylaxis and Risks of HIV and Sexually Transmitted Infections. Open Forum Infectious Diseases. 11(10). ofae569–ofae569. 2 indexed citations
13.
Loizzo, Jamie, et al.. (2024). Patients’ Perceptions of Cannabis Contamination in Florida's Medical Program. SHILAP Revista de lepidopterología. 8(1). 1–33.
14.
Vouri, Scott Martin, et al.. (2023). Incident mental health episodes after initiation of gabapentinoids vs. dopamine agonists for early-onset idiopathic restless legs syndrome. Psychiatry Research. 328. 115479–115479. 4 indexed citations
15.
Hincapie‐Castillo, Juan M., et al.. (2023). Pragmatic Model and Faculty Toolkit for PharmD Student Engagement in Social and Administrative Pharmacy Research. American Journal of Pharmaceutical Education. 87(5). 100014–100014. 1 indexed citations
16.
Babalonis, Shanna, et al.. (2023). Cannabis Effects on Driving Performance: Clinical Considerations. SHILAP Revista de lepidopterología. 6(1). 8–14. 3 indexed citations
17.
Park, Haesuk, Raj Desai, Xinyue Liu, et al.. (2022). Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis. Clinical Journal of the American Society of Nephrology. 17(6). 851–860. 4 indexed citations
18.
Goodin, Amie, et al.. (2020). Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review. Journal of the American Pharmacists Association. 61(2). e20–e44. 15 indexed citations
19.
20.
Freeman, Patricia R., et al.. (2015). Impact of Kentucky House bill 1 on concurrent prescribing of Opioid, Alprazolam, and Carisoprodol. Value in Health. 18(3). A128–A128. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip Clare Breakdown of academic impact, for papers by Anaïs Lacasse Breakdown of academic impact, for papers by Julie Dupouy Breakdown of academic impact, for papers by Stephen G. Henry Breakdown of academic impact, for papers by Gerald Cochran Breakdown of academic impact, for papers by Hillary V. Kunins Breakdown of academic impact, for papers by Darshak Sanghavi Breakdown of academic impact, for papers by Omid Ameli Breakdown of academic impact, for papers by Babak Tofighi Breakdown of academic impact, for papers by Lalitha Raman‐Wilms
Rankless by CCL
2026